GlassScriptPhysician profile
Sunil Nair
NPI 1306259866
$1,212.03
in general payments reported to CMS, 2019-2025
19 companies · $608 in 2025
The $608 reported for 2025 was more than what 92% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.70 · 2020: $51.96 · 2021: $220 · 2022: $96.14 · 2023: $34.17 · 2024: $186 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.00 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $441.25 | 2024-2025 | Fasenra, Airsupra, Tezspire |
| Janssen Pharmaceuticals, INC | $119.30 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.21 | 2021-2025 | Ofev |
| Becton, Dickinson and Company | $109.32 | 2025 | Hemosphere |
| Amgen INC. | $52.03 | 2021-2025 | Tezspire |
| Insmed, INC. | $46.81 | 2025 | Arikayce |
| E.R. Squibb & Sons, L.L.C. | $41.89 | 2020-2022 | |
| Ucb, INC. | $39.85 | 2022 | |
| Ambu INC. | $34.17 | 2023 | |
| Pfizer INC. | $32.43 | 2019-2022 | |
| Grifols USA, LLC | $31.51 | 2025 | Prolastin-C Liquid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.33 | 2020-2021 | |
| Medtronic, INC. | $25.75 | 2022 | |
| Genentech USA, INC. | $19.52 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $17.76 | 2024 | Uptravi, Opsumit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $17.36 | 2021 | |
| Celgene Corporation | $16.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.06 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.16 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.